Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Effect Size and Blinding in Lumateperone Trial.
The small GTPase Rab8 interacts with VAMP-3 to regulate the delivery of recycling T-cell receptors to the immune synapse.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effect Size and Blinding in Lumateperone Trial.
Gouse BM, Chang AL, Smith EG. Effect Size and Blinding in Lumateperone Trial. JAMA Psychiatry. 2020 06 01; 77(6):650-651.
View in:
PubMed
subject areas
Antipsychotic Agents
Heterocyclic Compounds, 4 or More Rings
Humans
Schizophrenia
authors with profiles
Eric G Smith MD, MPH